Mounjaro (tirzepatide) can cause lightheadedness through dehydration from reduced food and fluid intake, blood pressure changes from weight loss (particularly in patients taking antihypertensive medications), or low blood sugar when combined with insulin or sulfonylureas
Summary: GLP-1 agonists are not specifically licensed to treat leptin resistance, but they promote weight loss through mechanisms that work independently of leptin signalling pathways
Since everyone reacts differently to medication, knowing your health profile allows healthcare providers to adjust semaglutide treatment to fit your needs
Note: Using medication, such as Wegovy and Mounjaro, outside of its approved use should only be done under specific, expert medical supervision
The vast majority of personal injury cases, including those within an MDL, resolve through settlements before reaching a courtroom